Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases

Explore clinical trials studying Genital Diseases. Study availability and eligibility vary by location and protocol.

21,662 public trials 3,209 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases trial results

Recruiting

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

NCT05011383

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven, Connecticut, United States
  • North Florida/South Georgia Veterans Health System, Gainesville, FL Gainesville, Florida, United States
  • Orlando VA Medical Center, Orlando, FL Orlando, Florida, United States
View all 17 locations
View Trial Details
Recruiting

PSMA PET Combined With MRI for the Detection of PCa

NCT07052214

Conditions
Carcinoma of the Prostate, Diagnostic Imaging, Elevated PSA, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Impression Imaging Boca Raton, Florida, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Investigative Site #108 Goodyear, Arizona, United States
  • Investigative Site #101 La Jolla, California, United States
  • Investigative Site #111 San Francisco, California, United States
  • Investigative Site #104 Lake Mary, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NCT07524322

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Houston Houston, Texas, United States
  • NEXT San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 52 locations
View Trial Details

Related conditions